A detailed history of Mariner, LLC transactions in Twist Bioscience Corp stock. As of the latest transaction made, Mariner, LLC holds 8,747 shares of TWST stock, worth $405,860. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8,747
Previous 6,516 34.24%
Holding current value
$405,860
Previous $321,000 23.05%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$36.72 - $58.88 $81,922 - $131,361
2,231 Added 34.24%
8,747 $395,000
Q2 2024

Aug 13, 2024

SELL
$27.95 - $53.0 $124,042 - $235,214
-4,438 Reduced 40.51%
6,516 $321,000
Q1 2024

May 15, 2024

BUY
$32.28 - $41.5 $116,272 - $149,483
3,602 Added 48.99%
10,954 $375,000
Q4 2023

Feb 14, 2024

BUY
$15.08 - $38.61 $110,868 - $283,860
7,352 New
7,352 $270,000
Q3 2022

Nov 10, 2022

BUY
$33.44 - $56.56 $316,710 - $535,679
9,471 New
9,471 $334,000

Others Institutions Holding TWST

About Twist Bioscience Corp


  • Ticker TWST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 56,363,500
  • Market Cap $2.62B
  • Description
  • Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for d...
More about TWST
Track This Portfolio

Track Mariner, LLC Portfolio

Follow Mariner, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mariner, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mariner, LLC with notifications on news.